E-viri
Recenzirano
-
Lembo, Rosalba; Pisano, Antonio; Amantea, Bruno; Verdecchia, Claudio; Bove, Tiziana; Baldasarri, Rubia; Paternosta, Gianluca; Pappalardo, Federico; Bellomo, Rinaldo; Camata, Annamaria; Renzini, Massimo; Pasero, Daniela C; Alvaro, Gabriele; Persi, Bruno; Cariello, Claudia; Guarracino, Fabio; Checco, Erika Dal; Zuchetti, Maria C; Zangrillo, Alberto; Maglioni, Enivarco; Conte, Massimiliano; Galdieri, Nicola; Faita, Luana; Scandroglio, Anna M; Frontini, Mario; Calabro, Maria G; Caramelli, Fabio; Saleh, Omar; Martinez, Blanca; Landoni, Giovanni; Comis, Marco; Pinelli, Fulvio; Pala, Giovanni
JAMA : the journal of the American Medical Association, 12/2014, Letnik: 312, Številka: 21Journal Article
The article ascertains the efficacy of Fenoldopam infusion in cardiac patients with acute kidney injury (AKI). The research conducted included 667 participants in a multicenter, randomized, double-blind, placebo-controlled, parallel group study in Italy. The findings indicated that Fenoldopam intervention did not reduce the need for renal replacement therapy or 30-day mortality risk in patients with AKI compared with the placebo-controlled group and an increased rate of hypotension was observed.
